Thermo Fisher Scientific Inc.TMONYSE
Loading
A large-scale business, with solid profitability valued in line with the market.
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.
Comprehensive financial statement data for deep analysis
| Metric | Dec 21 | Dec 22 | Dec 23 | Dec 24 | Dec 25 |
|---|---|---|---|---|---|
| Return on Equity | - | - | - | - | - |
| Return on Invested Capital | - | - | - | - | - |
| Gross Margin | 50.1% | 42.3%↓15.5% | 40.1%↓5.2% | 41.3%↑3.1% | 37.7%↓8.9% |
| Operating Margin | 26.3% | 19.0%↓27.9% | 17.4%↓8.5% | 17.9%↑2.8% | 18.2%↑1.9% |
| Net Margin | 19.7% | 15.5%↓21.5% | 14.0%↓9.6% | 14.8%↑5.6% | 15.1%↑2.3% |
| Earnings Yield | - | - | - | - | - |